StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker FDA Recalls Normalized per $1B Revenue by Year

FDA Recalls Normalized per $1B Revenue (recalls / $1B) (×)

Stryker FDA Recalls Normalized per $1B Revenue: 1.10× in FY2025, down 38.9% from a year earlier. That is the lowest of the 8 years on record here.

Latest, FY2025
1.10
Period ended Dec 31, 2025
Change on a year earlier
-38.9%
1.80 in FY2024
History
8 years
Since FY2018
Sources
5
Documents cited below

Where the FY2025 figure comes from

Reported in Stryker Comprehensive Reports (2021–2025).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA Recalls Normalized per $1B Revenue (recalls / $1B) (×)Year on yearSource
FY2025Dec 31, 20251.10-38.9%2025 Comprehensive Report (ir|comp_report_2025) ↗
FY2024Dec 31, 20241.80+12.5%2025 Comprehensive Report (ir|comp_report_2025) ↗
FY2023Dec 31, 20231.600.0%2025 Comprehensive Report (ir|comp_report_2025) ↗
FY2022Dec 31, 20221.60-2.4%2024 Comprehensive Report (ir|comp_report_2024) ↗
FY2021Dec 31, 20211.64+31.2%2023 Comprehensive Report (ir|comp_report_2023) ↗
FY2020Dec 31, 20201.25-33.5%2022 Comprehensive Report (ir|comp_report_2022) ↗
FY2019Dec 31, 20191.88-41.3%2022 Comprehensive Report (ir|comp_report_2022) ↗
FY2018Dec 31, 20183.20–2021 Comprehensive Report (ir|comp_report_2021) ↗

Cite this data

StockData. (2026). Stryker FDA Recalls Normalized per $1B Revenue (×), annual FY2018–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/qual-rec-norm

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.